PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-12.95%
Negative net income growth while MCHP stands at 15.83%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
6.84%
Some D&A expansion while MCHP is negative at -11.53%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
95.38%
Lower deferred tax growth vs. MCHP's 4050.00%, implying fewer future tax liabilities. David Dodd would confirm there’s no short-term tax shock instead.
67.74%
SBC growth while MCHP is negative at -12.34%. John Neff would see competitor possibly controlling share issuance more tightly.
-9488.89%
Negative yoy working capital usage while MCHP is 9.06%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-87.59%
AR is negative yoy while MCHP is 49.19%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-50.42%
Negative yoy inventory while MCHP is 10.71%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
-464.71%
Negative yoy AP while MCHP is 28.17%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-236.97%
Both reduce yoy usage, with MCHP at -209.74%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
1.59%
Some yoy increase while MCHP is negative at -84.52%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-43.19%
Negative yoy CFO while MCHP is 12.40%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-1.55%
Both yoy lines negative, with MCHP at -6.37%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
18.30%
Purchases growth of 18.30% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
10.30%
Liquidation growth of 10.30% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in monetizing portfolio items that must be justified by market valuations.
81.82%
We have some outflow growth while MCHP is negative at -13.52%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
102.73%
We have mild expansions while MCHP is negative at -7.78%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-274.84%
Both yoy lines negative, with MCHP at -10.01%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
70.00%
We slightly raise equity while MCHP is negative at -42.74%. John Neff sees competitor possibly preserving share count or buying back shares.
87.85%
Repurchase growth above 1.5x MCHP's 24.81%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.